CRIS compared with RADX: revenue, margins and what each company keeps, and the suppliers and customers both name

CRISCuris Inc

Mkt capRevenueRevenue

RADXRadiopharm Theranostics Ltd

Mkt capRevenueRevenue

Compare

CRISCuris Inc

RADXRadiopharm Theranostics Ltd

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

CRISCuris Inc

0.61· pre 0.60

Mkt cap$1.3MRevenue$1MQ4 FY25Revenue$9MFY25

RADXRadiopharm Theranostics Ltd

1.11· pre 1.16

Pre-marketSep 2 '83

Mkt cap$3.8BRevenue—Revenue—

Compare

Pre-marketSep 2 '83

CRISCuris Inc

RADXRadiopharm Theranostics Ltd

0.61pre 0.60

Price

1.11pre 1.16

$1.3M

Mkt cap

$3.8B

Q4 FY25$1M

Revenue

—

FY25$9M

Revenue

—

CRIS0.61vsRADX1.11Pre-marketSep 2 '83

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CRIS: latest quarter not drawable. RADX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CRIS 1

—Genentechunlistedcustomer

Shared 0

No shared counterparties.

Only RADX 3

—AtomVieunlistedsupplier

—Diaprost ABunlistedsupplier

—Lantheusunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

CRIS, solidRADX, dashed